New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:03 EDTGTIV, KNDKindred says disappointed, but not deterred, by Gentiva 'poison pill'
Kindred Healthcare (KND) announded it sent a letter to the Gentiva Health (GTIV) Board of Directors in response to the poison pill, also known as a “shareholder rights plan,” implemented by the Gentiva Board and disclosed by Gentiva on Friday, May 23. In the letter, Kindred stated in part: "Since the May 15, 2014 public announcement of our offer to acquire Gentiva for total consideration of $14.00 per share, we have heard from both companies’ shareholders – and sell-side research analysts have reported – that they support a combination and that the price is a very compelling and significant premium to Gentiva’s historic trading price and projected earnings estimates. We are certain you have heard the same from your shareholders. We are disappointed, however, that instead of listening to your shareholders – the true owners of Gentiva – and immediately entering into good faith negotiations with Kindred, your Board has instead implemented a poison pill that limits shareholders’ opportunity to maximize the value of their investment. We question the motive and timing of such implementation, which limits not just Kindred, but all Gentiva shareholders from increasing their investment in the company...Despite Gentiva’s actions, we will not be deterred. We are determined to pursue the proposed combination of Kindred and Gentiva and are committed over the long-term to achieving our objective. We are ready, willing and able to quickly proceed toward consummating a negotiated transaction."
News For KND;GTIV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2015
17:51 EDTKND, GTIVS&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices
Subscribe for More Information
17:24 EDTGTIV, KNDANI Pharmaceuticals to replace Gentiva Health in S&P 600 as of 2/2 close
Subscribe for More Information
January 26, 2015
17:33 EDTKNDKindred Healthcare apponts Kent H. Wallace as COO
Kindred Healthcare has named Kent H. Wallace Executive VP and COO, effective February 2. Mr. Wallace will be a member of the company’s Executive Committee. Benjamin A. Breier, current COO, will become CEO on March 31, succeeding Paul J. Diaz, who will become Executive Vice Chairman of the Kindred Board of Directors.
January 22, 2015
16:17 EDTGTIV, KNDGentiva Health stockholders approve combination with Kindred Healthcare
Subscribe for More Information
16:06 EDTGTIV, KNDGentiva Health stockholders approve combo with Kindred Healthcare
Gentiva Health Services (GTIV) announced that all proposals necessary for the combination with Kindred Healthcare (KND) were approved by Gentiva’s stockholders at the company’s Special Meeting of Stockholders. Gentiva and Kindred expect to complete the transaction on February 2. As previously announced, on October 9, Kindred and Gentiva entered into a definitive agreement under which Kindred will combine with Gentiva for $14.50 per share in cash and 0.257 shares of Kindred common stock based upon an agreed upon fixed exchange ratio.
January 21, 2015
11:35 EDTKND, GTIVGentiva Health to host special shareholder meeting
Subscribe for More Information
January 16, 2015
10:47 EDTKNDBofA/Merrill healthcare facilities analyst analyst/industry conference call
Healthcare Facilities & Managed Care Analyst Bressler discusses the legislative and regulatory outlook for the industry for 2015 on an Analyst/Industry conference call to be held on January 23 at 2 pm.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use